Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dhiraj Gurjar

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Human Immunology|August 18, 2023
Decoding the contextual duality of CD40 functionsSyamdas Bandyopadhyay, Dhiraj Gurjar, Bhaskar Saha, et al.
Stem Cell Reviews and Reports|February 20, 2026
CD40 Stimulation Improves Osteogenesis from Mesenchymal Stem Cells via the Activation of TGF-βSananda Kumar Patra, Dhiraj Gurjar, Bhaskar Saha, et al.
Frontiers in Immunology|March 25, 2026
GenIV vaccines: bridging innovation to equity in neglected tropical diseasesMarta Araújo, Dhiraj Gurjar, Nicolas Grandchamp, et al.
Cytokine|July 5, 2022
Leishmania intercepts IFN-γR signaling at multiple levels in macrophagesDhiraj Gurjar, Sananda Kumar Patra, Neelam Bodhale, et al.
Virulence|September 8, 2025
Manipulation of macrophage signaling by <i>Leishmania</i> virulence factorsDhiraj Gurjar, Neelam Bodhale, Divanshu Shukla, et al.
Cytokine|May 4, 2024
Leishmania donovani mitogen-activated protein kinases as a host-parasite interaction interfaceNeelam Bodhale, Saptaparnee Saha, Dhiraj Gurjar, et al.
Cytokine|December 8, 2023
Aberrant expression of SOCS impairs the anti-leishmanial immune responseAbdollah Jafarzadeh, Dhiraj Gurjar, Neelam Bodhale, et al.
Parasitology International|March 16, 2026
Comparative proteomic profiling reveals distinct molecular signatures of drug resistance in clinical isolates of Leishmania donovaniDhiraj Gurjar, Baibaswata Saha, Kalpana Pai, et al.
Cytokine|May 17, 2026
TGF-beta inhibitors influence leishmania infection outcome in a susceptible hostSusmita Barik, Monalisa Ray, Dhiraj Gurjar, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Human Immunology|August 18, 2023
Decoding the contextual duality of CD40 functionsSyamdas Bandyopadhyay, Dhiraj Gurjar, Bhaskar Saha, et al.
Stem Cell Reviews and Reports|February 20, 2026
CD40 Stimulation Improves Osteogenesis from Mesenchymal Stem Cells via the Activation of TGF-βSananda Kumar Patra, Dhiraj Gurjar, Bhaskar Saha, et al.
Frontiers in Immunology|March 25, 2026
GenIV vaccines: bridging innovation to equity in neglected tropical diseasesMarta Araújo, Dhiraj Gurjar, Nicolas Grandchamp, et al.
Cytokine|July 5, 2022
Leishmania intercepts IFN-γR signaling at multiple levels in macrophagesDhiraj Gurjar, Sananda Kumar Patra, Neelam Bodhale, et al.
Virulence|September 8, 2025
Manipulation of macrophage signaling by <i>Leishmania</i> virulence factorsDhiraj Gurjar, Neelam Bodhale, Divanshu Shukla, et al.
Cytokine|May 4, 2024
Leishmania donovani mitogen-activated protein kinases as a host-parasite interaction interfaceNeelam Bodhale, Saptaparnee Saha, Dhiraj Gurjar, et al.
Cytokine|December 8, 2023
Aberrant expression of SOCS impairs the anti-leishmanial immune responseAbdollah Jafarzadeh, Dhiraj Gurjar, Neelam Bodhale, et al.
Parasitology International|March 16, 2026
Comparative proteomic profiling reveals distinct molecular signatures of drug resistance in clinical isolates of Leishmania donovaniDhiraj Gurjar, Baibaswata Saha, Kalpana Pai, et al.
Cytokine|May 17, 2026
TGF-beta inhibitors influence leishmania infection outcome in a susceptible hostSusmita Barik, Monalisa Ray, Dhiraj Gurjar, et al.
Pageof 1